COVID-19 – Page 2 – Foundation for Women's Cancer
A- A A+

COVID-19: Considerations for Gynecologic Cancer Patients

As someone who is coping with a gynecologic cancer, you may have questions about how the novel coronavirus (COVID-19) pandemic might impact your treatment or follow-up appointments. Specific treatment recommendations need to be made in conjunction with your gynecologic oncologist based on the goals of your treatment, clinical status and risks versus benefits.

The COVID-19 pandemic is changing daily, with states, municipalities and institutions making changes in how they’re handling quarantine and critical health care, so check with your health care team as needed. Your gynecologic cancer care team is working hard to do the best they can for their patients given the circumstances.

In this environment of social distancing you may be hearing more about telemedicine, which is the remote delivery of health care services such as exams and consultations. Telemedicine software enables medical providers to diagnose or treat patients remotely using secure telecommunications tools like video chats, online portals, phone calls or email.

Official policies for health care institutions are rapidly changing at this time, and may vary based on geographic region, but here are a few things to keep in mind.

General considerations

  • Your doctor’s office might need to pre-screen you via telephone/patient portal for COVID-19 symptoms the day before a clinic appointment, and repeat the screening during patient check-in. This may include having your temperature taken.
  • You may be limited to having one person accompany you to an outpatient appointment; it is possible that you won’t be allowed to bring someone with you.
  • Maintain physical distancing in waiting areas; your doctor’s practice may have to schedule fewer patients at a time so there will be less people in the waiting area.
  • You may have to minimize clinic/hospital/laboratory visits in favor of telemedicine visits and home-based or local collection of labs.
  • You may have to reschedule asymptomatic surveillance visits and conduct routine postoperative visits and discussion of pathology results with telemedicine.
  • If you are in active treatment, your doctor may consider chemotherapy regimens that will avoid frequent clinic visits.
  • Second opinions may be accomplished with the use of telemedicine, as resources allow.
  • Enrollment and treatment in clinical trials may be delayed or halted based on the availability of clinical and research support at your institution.
  • If you are already in a clinical trial, verify with your research team the status of your trial.
  • If you are a candidate for surgery, the procedure may be scheduled as usual or delayed as appropriate, depending on various factors to be determined by your gynecologic oncologist in conjunction with institutional and/or government agency recommendations.

FWC thanks the following sponsors for their support of our COVID-19 resources:

 

 

 

Food Safety During COVID-19

Wednesday, April 15, 2020

How to Safely Handle Food During the COVID-19 Crisis Even though COVID-19 is not transmitted through foods, there is a concern about the virus being passed on through food handling or other shoppers. If you live in a household that has been impacted by a cancer diagnosis, it is more important than ever to properly … Read More

April 10 Webinar on COVID-19 and Gyn Cancer Patients

Wednesday, April 8, 2020

April 10 Webinar: What the COVID-19 Crisis Means for Gynecologic Cancer Patients Join SHARE and the Foundation for Women’s Cancer hosted a webinar April 10, 2020, What the COVID-19 Crisis Means for Gynecologic Cancer Patients. The coronavirus pandemic has added an extra layer of uncertainty to the lives of cancer patients. Join Stephanie V. Blank, … Read More

April 8 #GYNCSM COVID-19 Tweetchat

Monday, April 6, 2020

April 8, 2020: ‘Open Mic’ #GYNCSM Tweetchat on COVID-19 UPDATE (April 9, 2020): Read the blog post synopsis and full transcript from the April 8 Open Mic Tweetchat on COVID-19. Hear from the Society of Gynecologic Oncology (SGO) COVID-19 Task Force co-chairs Amanda Nickles Fader, MD, Joshua Kesterson, MD, Bhavana Pothuri, MD, MS, and patient … Read More

COVID-19 Helpful Resources

Monday, March 30, 2020

(Updated May 5, 2020) During this uncertain time, there is a lot of evolving information regarding the novel coronavirus (COVID-19). Health care practitioners around the world are working to ensure that they are providing the best possible care for their patients. Resources for cancer patients are being added and modified on a regular basis. Rapidly … Read More

Foundation for Women’s Cancer Response to COVID-19

Saturday, March 28, 2020

Foundation for Women’s Cancer: Message from the CEO Pierre Désy, MPH, CAE, Chief Executive Officer of the Society of Gynecologic Oncology and Foundation for Women’s Cancer, shares a heartfelt message during this unprecedented time of uncertainty.